Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases

[1]  M. Sun,et al.  [Lipofibromatosis: a clinicopathological analysis of eight cases]. , 2018, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[2]  P. Pal,et al.  ROS1-1 , 2017, Journal of Clinical Pathology.

[3]  M. Lim,et al.  Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  S. Cull-Candy,et al.  Structural and Functional Architecture of AMPA-Type Glutamate Receptors and Their Auxiliary Proteins , 2017, Neuron.

[5]  J. Custódio,et al.  Ionotropic glutamate receptor antagonists and cancer therapy: time to think out of the box? , 2017, Cancer Chemotherapy and Pharmacology.

[6]  A. Folpe,et al.  Fibrous hamartoma of infancy: a clinicopathologic study of 145 cases, including 2 with sarcomatous features , 2017, Modern Pathology.

[7]  Jason Y. Park,et al.  EGFR Exon 20 Insertion/Duplication Mutations Characterize Fibrous Hamartoma of Infancy , 2016, The American journal of surgical pathology.

[8]  Narasimhan P. Agaram,et al.  Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors , 2016, The American journal of surgical pathology.

[9]  C. Strahlendorf,et al.  ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors , 2016, The American journal of surgical pathology.

[10]  Y. Oda,et al.  ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours , 2016, Histopathology.

[11]  C. Antonescu,et al.  Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes , 2016, Genes, chromosomes & cancer.

[12]  F. Mertens,et al.  FN1–EGF gene fusions are recurrent in calcifying aponeurotic fibroma , 2016, The Journal of pathology.

[13]  C. Antonescu,et al.  Molecular Characterization of Inflammatory Myofibroblastic Tumors With Frequent ALK and ROS1 Gene Fusions and Rare Novel RET Rearrangement , 2015, The American journal of surgical pathology.

[14]  D. Gisselsson,et al.  Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing , 2015, Laboratory Investigation.

[15]  M. Caraglia,et al.  PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy , 2015, Endocrine.

[16]  O. Kallioniemi,et al.  FusionCatcher – a tool for finding somatic fusion genes in paired-end RNA-sequencing data , 2014, bioRxiv.

[17]  Nicolas Stransky,et al.  The landscape of kinase fusions in cancer , 2014, Nature Communications.

[18]  P. Stephens,et al.  Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. , 2014, Cancer discovery.

[19]  J. Dormans,et al.  Lipofibromatosis: An Institutional and Literature Review of an Uncommon Entity , 2014, Pediatric dermatology.

[20]  T. Fioretos,et al.  A novel SERPINE1–FOSB fusion gene results in transcriptional up‐regulation of FOSB in pseudomyogenic haemangioendothelioma , 2014, The Journal of pathology.

[21]  A. D. Dei Tos,et al.  Lipofibromatosis: magnetic resonance imaging features and pathological correlation in three cases , 2014, Skeletal Radiology.

[22]  K. Tamama,et al.  Early Growth Response Genes Signaling Supports Strong Paracrine Capability of Mesenchymal Stem Cells , 2012, Stem cells international.

[23]  B. Gharibi,et al.  Akt- and Erk-mediated regulation of proliferation and differentiation during PDGFRβ-induced MSC self-renewal , 2012, Journal of cellular and molecular medicine.

[24]  Christopher A. Maher,et al.  ChimeraScan: a tool for identifying chimeric transcription in sequencing data , 2011, Bioinform..

[25]  W. Tourtellotte,et al.  Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy. , 2011, Matrix biology : journal of the International Society for Matrix Biology.

[26]  Yosef Yarden,et al.  Feedback regulation of EGFR signalling: decision making by early and delayed loops , 2011, Nature Reviews Molecular Cell Biology.

[27]  Geraldo Pereira Jotz,et al.  Glutamate Promotes Cell Growth by EGFR Signaling on U-87MG Human Glioblastoma Cell Line , 2010, Pathology & Oncology Research.

[28]  Jeffrey A. Engelman,et al.  Targeting PI3K signalling in cancer: opportunities, challenges and limitations , 2009, Nature Reviews Cancer.

[29]  E. Zambrano,et al.  Chromosomal rearrangements in lipofibromatosis. , 2007, Cancer genetics and cytogenetics.

[30]  Y. Yoshida,et al.  Ca2+-Permeable AMPA Receptors Regulate Growth of Human Glioblastoma via Akt Activation , 2007, The Journal of Neuroscience.

[31]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[32]  M. Miettinen,et al.  A Clinicopathologic Study of 45 Pediatric Soft Tissue Tumors With an Admixture of Adipose Tissue and Fibroblastic Elements, and a Proposal for Classification as Lipofibromatosis , 2000, The American journal of surgical pathology.

[33]  P. D. Dal Cin,et al.  TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. , 2000, The American journal of pathology.

[34]  C. Griffin,et al.  Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. , 1999, Cancer research.

[35]  M. Miettinen,et al.  Calcifying aponeurotic fibroma: a clinicopathologic study of 22 cases arising in uncommon sites. , 1998, Human pathology.

[36]  Stout Ap.  The fibromatoses and fibrosarcoma. , 1951 .

[37]  J. Kobos,et al.  Lipofibromatosis presenting as a neck mass in eight-years old boy--a case report. , 2008, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[38]  R. Brekken,et al.  SPARC, a matricellular protein: at the crossroads of cell-matrix communication. , 2001, Matrix biology : journal of the International Society for Matrix Biology.